US 5,650,298 Β· Granted 1997-07-22

Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters

Transgenic animals carrying two transgenes, the first coding for a transactivator fusion protein comprising a tet repressor and a polypeptide which directly or indirectly activates in eucaryotic cells, and the second comprising a gene operably linked to a minimal promoter operably linked to at least one tet operator sequence, are disclosed. Isolated DNA molecules (e.g., targeting vectors) for integrating a polynucleotide sequence encoding a transactivator of the invention at a predetermined location within a second target DNA molecule by homologous recombination are also disclosed. Transgenic animals having the DNA molecules of the invention integrated at a predetermined location in a chromosome by homologous recombination are also encompassed by the invention. Methods to regulate the expression of a tet operator linked-gene of interest by administering tetracycline or a tetracycline analogue to an animal of the invention are also disclosed. The regulatory system of the invention allows for conditional inactivation or modulation of expression of a gene of interest in a host cell or animal.

Patent details

Publication number
US 5,650,298
Filing date
1994-06-14
Grant date
1997-07-22
Assignee
Basf Aktiengesellschaft / Knoll Aktiengesellschaft
Inventor(s)
BUJARD; HERMANN, GOSSEN; MANFRED, SALFELD; JOCHEN G., VOSS; JEFFREY W.
CPC class
A01K67/0275

Want to file your own patent?

Run your idea through our free scanner β€” we’ll show you which existing patents are conceptually closest, including this one if it’s a match.

Free patentability scan